相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction
Qiang Li et al.
EMBO REPORTS (2022)
Pathway network of pyroptosis and its potential inhibitors in acute kidney injury
Ning Li et al.
PHARMACOLOGICAL RESEARCH (2022)
Caloric restriction in humans reveals immunometabolic regulators of health span
O. Spadaro et al.
SCIENCE (2022)
An RRx-001 Analogue With Potent Anti-NLRP3 Inflammasome Activity but Without High-Energy Nitro Functional Groups
Hualong Lin et al.
FRONTIERS IN PHARMACOLOGY (2022)
β-arrestin-2 alleviates rheumatoid arthritis injury by suppressing NLRP3 inflammasome activation and NF-κB pathway in macrophages
Feng Cao et al.
BIOENGINEERED (2022)
TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expression
Hirofumi Tenshin et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)
Discovery of a novel and potent inhibitor with differential species-specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis
Yan Jiao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Bidirectional Role of NLRP3 During Acute and Chronic Cholestatic Liver Injury
Mick Frissen et al.
HEPATOLOGY (2021)
Increasing complexity of NLRP3 inflammasome regulation
Julien Moretti et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2021)
NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation
Liudmila Andreeva et al.
CELL (2021)
Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space
Adam G. Schwaid et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
An update on the regulatory mechanisms of NLRP3 inflammasome activation
Seungwha Paik et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor
Yun Chen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases
Yiwen Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Protectin DX restores Treg/Th17 cell balance in rheumatoid arthritis by inhibiting NLRP3 inflammasome via miR-20a
Shengwei Jin et al.
CELL DEATH & DISEASE (2021)
Hsa_circ_0044235 regulates the pyroptosis of rheumatoid arthritis via MiR-135b-5p-SIRT1 axis
Shaojian Chen et al.
CELL CYCLE (2021)
Celastrol inhibits rheumatoid arthritis through the ROS-NF-κB-NLRP3 inflammasome axis
Ming Jing et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Cell biology of inflammasome activation
Abhimanu Pandey et al.
TRENDS IN CELL BIOLOGY (2021)
NLRP3 gene polymorphisms and expression in rheumatoid arthritis
Lin Cheng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition
Hua Zhu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Tofacitinib restores the balance of γδTreg/γδT17 cells in rheumatoid arthritis by inhibiting the NLRP3 inflammasome
Xinyu Yang et al.
THERANOSTICS (2021)
ACPAs promote IL-1β production in rheumatoid arthritis by activating the NLRP3 inflammasome
Xiwen Dong et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases
J. Michelle Kahlenberg et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Inflammasomes contributing to inflammation in arthritis
Lotte Spel et al.
IMMUNOLOGICAL REVIEWS (2020)
Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators
Dongling Liu et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
Carolina Pellegrini et al.
PROGRESS IN NEUROBIOLOGY (2020)
Cinnamaldehyde suppresses NLRP3 derived IL-1β via activating succinate/HIF-1 in rheumatoid arthritis rats
Panwang Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Circadian Control of Inflammasome Pathways: Implications for Circadian Medicine
Benoit Pourcet et al.
FRONTIERS IN IMMUNOLOGY (2020)
Icariin alleviates rheumatoid arthritis via regulating miR-223-3p/NLRP3 signalling axis
Zhi-Ming Wu et al.
AUTOIMMUNITY (2020)
Role of the NLRP3 inflammasome in autoimmune diseases
Zhe Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis
Elisabeth Jaeger et al.
NATURE COMMUNICATIONS (2020)
Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI
Yuhua Chen et al.
BRAIN RESEARCH (2019)
Taraxasterol suppresses inflammation in IL-1β-induced rheumatoid arthritis fibroblast-like synoviocytes and rheumatoid arthritis progression in mice
Jianfeng Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
MCC950 directly targets the NLRP3 ATP- hydrolysis motif for inflammasome inhibition
Rebecca C. Coll et al.
NATURE CHEMICAL BIOLOGY (2019)
MCC950 closes the active conformation of NLRP3 to an inactive state
Ana Tapia-Abelian et al.
NATURE CHEMICAL BIOLOGY (2019)
Reconstitution and structure of a plant NLR resistosome conferring immunity
Jizong Wang et al.
SCIENCE (2019)
MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
Gulcin Tezcan et al.
FRONTIERS IN PHARMACOLOGY (2019)
Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review
Jae Il Shin et al.
JOURNAL OF AUTOIMMUNITY (2019)
IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis
Erin Fahey et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Plant Resistosome: Structural Insights into Immune Signaling
Hayden Burdett et al.
CELL HOST & MICROBE (2019)
Hyperactivation of the NLRP3 inflammasome protects mice against influenza A virus infection via IL-1β mediated neutrophil recruitment
Junling Niu et al.
CYTOKINE (2019)
DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome
Parimal Samir et al.
NATURE (2019)
Omnipresence of inflammasome activities in inflammatory bone diseases
Yael Alippe et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination
Zebing Rao et al.
FRONTIERS IN IMMUNOLOGY (2019)
Interaction between autophagy and the NLRP3 inflammasome
Zhenrui Cao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
NLRP3: A promising therapeutic target for autoimmune diseases
Hui-Hui Shen et al.
AUTOIMMUNITY REVIEWS (2018)
Tranilast directly targets NLRP3 to treat inflammasome-driven diseases
Yi Huang et al.
EMBO MOLECULAR MEDICINE (2018)
Anakinra for the treatment of rheumatoid arthritis: a safety evaluation
Julio Ramirez et al.
EXPERT OPINION ON DRUG SAFETY (2018)
Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity
Dave Boucher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Role of inflammasomes in inflammatory autoimmune rheumatic diseases
Young-Su Yi
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Induction of NLRP3 Inflammasome Activation by Heme in Human Endothelial Cells
Judit Erdei et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome
Fiachra Humphries et al.
NATURE COMMUNICATIONS (2018)
NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis
C. Guo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation
Jueqi Chen et al.
NATURE (2018)
Dendritic cells as gatekeepers of tolerance
Ari Waisman et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Inflammasome activation and assembly at a glance
Ankit Malik et al.
JOURNAL OF CELL SCIENCE (2017)
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
Hua Jiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain
Andrea Stutz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Protein kinase D at the Golgi controls NLRP3 inflammasome activation
Zhirong Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation
Evan Lusty et al.
MOLECULAR IMMUNOLOGY (2017)
Pro-inflammatory Ca++-activated K+ channels are inhibited by hydroxychloroquine
Maria Eugenia Schroeder et al.
SCIENTIFIC REPORTS (2017)
Downregulated NLRP3 and NLRP1 inflammasomes signaling pathways in the development and progression of type 1 diabetes mellitus
Huawei Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Infections in rheumatoid arthritis
Fabiola Atzeni et al.
CURRENT OPINION IN RHEUMATOLOGY (2017)
Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors
Christina E. Smith et al.
CELL CHEMICAL BIOLOGY (2017)
Shiga Toxins Activate the NLRP3 Inflammasome Pathway To Promote Both Production of the Proinflammatory Cytokine Interleukin-1 beta and Apoptotic Cell Death
Moo-Seung Lee et al.
INFECTION AND IMMUNITY (2016)
A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation
Jonathan L. Schmid-Burgk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component
Hexin Shi et al.
NATURE IMMUNOLOGY (2016)
Human Monocytes Engage an Alternative Inflammasome Pathway
Moritz M. Gaidt et al.
IMMUNITY (2016)
Old and new therapeutics for Rheumatoid Arthritis: in vivo models and drug development
Samra Sardar et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2016)
Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner
Zhaowen Yang et al.
JOINT BONE SPINE (2016)
The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation
Deepika Sharma et al.
JOURNAL OF CELL BIOLOGY (2016)
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22
Marianne R. Spalinger et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
NLRP3 Inflammasome Plays an Important Role in the Pathogenesis of Collagen-Induced Arthritis
Yongfeng Zhang et al.
MEDIATORS OF INFLAMMATION (2016)
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Xing Liu et al.
NATURE (2016)
NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
Yuan He et al.
NATURE (2016)
NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations
Leanne Mortimer et al.
NATURE IMMUNOLOGY (2016)
The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3
Hui Song et al.
NATURE COMMUNICATIONS (2016)
Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition
Michelle D. Tate et al.
SCIENTIFIC REPORTS (2016)
NLRP3 AND CARD8 POLYMORPHISMS INFLUENCE HIGHER DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
Barbara Jenko et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2016)
Inflammasomes: mechanism of assembly, regulation and signalling
Petr Broz et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
Yiqing Yan et al.
CELL (2015)
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
Wan-ting He et al.
CELL RESEARCH (2015)
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1 via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients
P. Ruscitti et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Non-canonical activation of inflammatory caspases by cytosolic LPS in innate immunity
Jieling Yang et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
The Role of IL-1β in the Bone Loss during Rheumatic Diseases
Piero Ruscitti et al.
MEDIATORS OF INFLAMMATION (2015)
Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine
O. J. Harrison et al.
MUCOSAL IMMUNOLOGY (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis
Christianna Choulaki et al.
ARTHRITIS RESEARCH & THERAPY (2015)
NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-β receptor signalling
Maciej Lech et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
Stefan Siebert et al.
PHARMACOLOGICAL REVIEWS (2015)
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment
Rebeccah J. Mathews et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Alvin Lu et al.
CELL (2014)
Localization and Functionality of the Inflammasome in Neutrophils*
Martina Bakele et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes
Prajwal Gurung et al.
JOURNAL OF IMMUNOLOGY (2014)
Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
Lieselotte Vande Walle et al.
NATURE (2014)
Inflammatory caspases are innate immune receptors for intracellular LPS
Jianjin Shi et al.
NATURE (2014)
Anti-TNF Treatment Response in Rheumatoid Arthritis Patients Is Associated with Genetic Variation in the NLRP3-Inflammasome
Jacob Sode et al.
PLOS ONE (2014)
IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation
Keng-Mean Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction
Claire J. Greenhill et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Role of NLRP3 and NLRP1 inflammasomes signaling pathways in pathogenesis of rheumatoid arthritis
Tao Wang et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2014)
The Neutrophil NLRC4 Inflammasome Selectively Promotes IL-1β Maturation without Pyroptosis during Acute Salmonella Challenge
Kaiwen W. Chen et al.
CELL REPORTS (2014)
IL-18 Upregulates the Production of Key Regulators of Osteoclastogenesis from Fibroblast-Like Synoviocytes in Rheumatoid Arthritis
Wei Zhang et al.
INFLAMMATION (2013)
Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies
Susannah D. Brydges et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity
Benedicte F. Py et al.
MOLECULAR CELL (2013)
Activation and regulation of the inflammasomes
Eicke Latz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction
Chong-Shan Shi et al.
NATURE IMMUNOLOGY (2012)
Inflammatory bone loss: pathogenesis and therapeutic intervention
Kurt Redlich et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
The NLRP3 Inflammasome Is Differentially Activated by Pneumolysin Variants and Contributes to Host Defense in Pneumococcal Pneumonia
Martin Witzenrath et al.
JOURNAL OF IMMUNOLOGY (2011)
Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1
M. Maroso et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Non-canonical inflammasome activation targets caspase-11
Nobuhiko Kayagaki et al.
NATURE (2011)
The NIrp3 inflammasome: contributions to intestinal homeostasis
Md Hasan Zaki et al.
TRENDS IN IMMUNOLOGY (2011)
The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice
N. Shiota et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Immunological and Inflammatory Functions of the Interleukin-1 Family
Charles A. Dinarello
ANNUAL REVIEW OF IMMUNOLOGY (2009)
An Essential Role for the NLRP3 Inflammasome in Host Defense against the Human Fungal Pathogen Candida albicans
Amy G. Hise et al.
CELL HOST & MICROBE (2009)
Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation
Luigi Franchi et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
Anakinra for Rheumatoid Arthritis: A Systematic Review
Marty Mertens et al.
JOURNAL OF RHEUMATOLOGY (2009)
Tranilast suppresses the disease development of the adjuvant- and streptococcal cell wall-induced arthritis in rats
Toshiaki Nagate et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation
T. Fernandes-Alnemri et al.
CELL DEATH AND DIFFERENTIATION (2007)
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18
Woods Wannamaker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis
Lars Klareskog et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
NLRs join TLRs as innate sensors of pathogens
F Martinon et al.
TRENDS IN IMMUNOLOGY (2005)
Apoptosis-based therapies and drug targets
U Fischer et al.
CELL DEATH AND DIFFERENTIATION (2005)
The role of interleukin-1 in bone resorption in rheumatoid arthritis
V. Strand et al.
RHEUMATOLOGY (2004)
Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
分享论文
